Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Etomidate for Recovery Quality in Elderly Day Surgery
NCT05748665Completed
- Sponsor
- Xijing Hospital
- Start
- Aug 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in general anesthesia (2 arms), sponsored by Xijing Hospital. Primary endpoint: Quality of Recovery 15. Started Aug 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT05748665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05748665.